| Literature DB >> 30789458 |
Nicholas Placone1, Roy L Kao2,3, Pamela Kempert2,3, Maritza E Ruiz2,3, Jacqueline N Casillas2,3, Maki Okada2, James B Gibson4, Carlos Maggi2, Kevin O'Brien2, Roy Nattiv2,5, Natalie M Gallant2,6, Stephanie H Abrams2,5.
Abstract
Idiopathic hyperammonemia is a rare, poorly understood, and often lethal condition that has been described in immunocompromised patients. This report describes an immunocompromised patient with acute myelogenous leukemia who developed persistent hyperammonemia up to 705 µmol/L (normal, 0 to 47 µmol/L) refractory to multiple different therapies. However, after beginning azithromycin and then doxycycline therapy for Ureaplasma species infection, the patient showed immediate and sustained clinical improvement and resolution of ammonia levels. Recognizing disseminated Ureaplasma species infection as a potential cause of idiopathic hyperammonemia, an unexplained, often fatal condition in immunocompromised patients, and empirically treating for this infection could potentially be lifesaving.Entities:
Mesh:
Substances:
Year: 2020 PMID: 30789458 DOI: 10.1097/MPH.0000000000001414
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289